Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness

Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WIS...

Full description

Saved in:
Bibliographic Details
Published inClinical & translational oncology Vol. 27; no. 2; pp. 580 - 592
Main Authors Fu, C., Lu, Z., Shi, J., Liu, F., Su, X.
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.02.2025
Subjects
Online AccessGet full text
ISSN1699-3055
1699-3055
DOI10.1007/s12094-024-03639-6

Cover

Abstract Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC. Methods Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial–mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined. Results WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo. Conclusion Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness.
AbstractList Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC. Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined. WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo. Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.
Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.OBJECTIVEWnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.METHODSGenes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.RESULTSWISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.CONCLUSIONKnockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.
Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC. Methods Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial–mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined. Results WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo. Conclusion Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness.
Author Su, X.
Lu, Z.
Shi, J.
Fu, C.
Liu, F.
Author_xml – sequence: 1
  givenname: C.
  surname: Fu
  fullname: Fu, C.
  organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University
– sequence: 2
  givenname: Z.
  surname: Lu
  fullname: Lu, Z.
  organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University
– sequence: 3
  givenname: J.
  surname: Shi
  fullname: Shi, J.
  organization: Department of Ultrasound, Zhongda Hospital, Medical School, Southeast University
– sequence: 4
  givenname: F.
  surname: Liu
  fullname: Liu, F.
  organization: Department of Medical Oncology, Luhe People’s Hospital of Nanjing
– sequence: 5
  givenname: X.
  orcidid: 0000-0001-6486-3110
  surname: Su
  fullname: Su, X.
  email: suxiangyu1982@163.com
  organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39093516$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1DAUhS1URH_gBVggL9mE2vHYiZeolFJNJZBaqUvLcW5mXBI79U2Esus7dN2X40nwMAWxYnHlu_jOuTo-x-QgxACEvOXsA2esOkVeMr0qWJlHKKEL9YIccaV1IZiUB__sh-QY8Y7lTXH-ihwKzbSQXB2Rp3WI7nsbfwQaO3p7ef2Nn35arzlNgFOyPiAdtxDitIze0bG3OHnnp4X6QAHjuLUbsD3F-9kOcUbqoO-ps8n5EAdLm4XiPI7ZDH3YUBj9tIXe2_7nw-MACMFtlyHr86mAfvIxUBtaihMMIWtek5ed7RHePL8n5Obz-c3Zl-Lq68Xl2cerwpW6ngou69Y5ZSuohJSwcqyGUrVKSN0p21SicxK6Soq6tI1mK7BCV6uy49I2rHTihLzf244p3s85uBk87pLYADmUEazOxqrUPKPvntG5GaA1Y_KDTYv586MZKPeASxExQfcX4czsajP72kyuzfyuzexEYi_CDIcNJHMX5xRy5P-pfgGuvZ8L
Cites_doi 10.1007/978-1-0716-0377-2_1
10.1177/1535370221992703
10.18632/aging.203430
10.1016/j.envint.2021.106880
10.1007/s10735-011-9347-1
10.1093/jrr/rrw030
10.1038/s41467-022-29018-9
10.1016/j.apsb.2021.03.009
10.1177/0960327113510537
10.1158/2159-8290.CD-21-1059
10.18632/oncotarget.4529
10.2147/CMAR.S275172
10.1007/s12195-019-00602-2
10.1074/jbc.RA118.006122
10.1016/j.pharmthera.2020.107692
10.3390/ijms23031353
10.21037/jgo-2019-gi-08
10.1158/2159-8290.CD-21-0282
10.2174/1567202617666200327125257
10.1016/bs.acr.2019.05.004
10.1080/21655979.2022.2068738
10.1111/j.1442-2050.2011.01279.x
10.15761/JTS.1000112
10.3892/or.2022.8333
10.18632/oncotarget.3358
10.1016/j.biocel.2008.07.025
10.30802/AALAS-JAALAS-18-000005
10.1016/j.stem.2018.11.011
10.1016/j.ydbio.2017.07.025
10.1111/bph.13894
10.1038/s41388-021-01860-z
10.3390/cancers13051009
10.2174/138945008784911750
10.1111/jcmm.12862
10.2174/1567202611666140912115107
10.1007/s10555-023-10087-1
10.1016/j.biocel.2015.03.007
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Copyright_xml – notice: The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s12094-024-03639-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1699-3055
EndPage 592
ExternalDocumentID 39093516
10_1007_s12094_024_03639_6
Genre Journal Article
GrantInformation_xml – fundername: Research project of Jiangsu Provincial Health Commission
  grantid: No.M2022073
– fundername: hinese and Western Medicine Collaborative Medical Research Project, Zhongda Hospital, Southeast University
  grantid: No.2023zxyxt11
GroupedDBID -05
-0E
-5E
-5G
-BR
-EM
-S~
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29B
29~
2B.
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VR
5VS
67Z
6NX
8TC
8UJ
92I
92M
93N
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACZOJ
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
BSONS
CAG
CCEZO
CHBEP
CIEJG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FA0
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG5
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JUIAU
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
P9S
PF0
PT4
Q--
Q-4
QOR
QOS
R89
R9I
ROL
RPX
RSV
RT5
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T8U
TCJ
TSG
TSK
TSV
TT1
TUC
U1F
U1G
U2A
U5O
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z45
Z7D
Z7U
Z82
Z87
ZMTXR
ZOVNA
~A9
~N8
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ABRTQ
ID FETCH-LOGICAL-c298t-158dcc6a7e7355e4c08e26d6359f6ab73fc5ef75382ab904ea39742f15ab02c3
IEDL.DBID AGYKE
ISSN 1699-3055
IngestDate Fri Sep 05 07:56:17 EDT 2025
Fri Apr 25 03:25:47 EDT 2025
Tue Jul 01 03:55:56 EDT 2025
Fri Feb 21 02:36:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Wnt1 inducible signaling pathway protein 1
Phenotypic plasticity
Esophageal squamous cell carcinoma
Dickkopf-1
Metastasis
Language English
License 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c298t-158dcc6a7e7355e4c08e26d6359f6ab73fc5ef75382ab904ea39742f15ab02c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6486-3110
PMID 39093516
PQID 3087356291
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_3087356291
pubmed_primary_39093516
crossref_primary_10_1007_s12094_024_03639_6
springer_journals_10_1007_s12094_024_03639_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-02-01
PublicationDateYYYYMMDD 2025-02-01
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Italy
PublicationTitle Clinical & translational oncology
PublicationTitleAbbrev Clin Transl Oncol
PublicationTitleAlternate Clin Transl Oncol
PublicationYear 2025
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References H Li (3639_CR7) 2022
M Katoh (3639_CR21) 2008; 9
K Fousek (3639_CR28) 2021; 219
H Begenik (3639_CR40) 2014; 33
M Wu (3639_CR20) 2022; 13
C O'Brien-Ball (3639_CR29) 2017; 430
D Song (3639_CR35) 2021; 246
DB Burkhardt (3639_CR27) 2022; 12
MH Kagey (3639_CR38) 2017; 174
D Hanahan (3639_CR8) 2022; 12
J Tímár (3639_CR37) 2023; 42
G Sun (3639_CR24) 2022; 237
SX Han (3639_CR17) 2015; 6
G Zhu (3639_CR39) 2021; 13
AK Lam (3639_CR2) 2020; 2129
Y Wang (3639_CR23) 2012; 25
VJ Grille (3639_CR5) 2021; 12
H Jiang (3639_CR16) 2022; 13
W Deng (3639_CR34) 2020; 13
S Li (3639_CR43) 2011; 42
Y Zhao (3639_CR1) 2021; 11
MA Creamer-Hente (3639_CR22) 2018; 57
A Barzegar Behrooz (3639_CR30) 2022; 23
I Gurbuz (3639_CR32) 2015; 62
K Maiese (3639_CR9) 2016; 1
L Qiu (3639_CR6) 2022; 546
H Kimura (3639_CR19) 2021; 40
CC Chen (3639_CR10) 2009; 41
Q Song (3639_CR41) 2021; 13
PB Gupta (3639_CR26) 2019; 24
H Zhang (3639_CR14) 2015; 6
Y Nagai (3639_CR33) 2011; 31
M Tarazi (3639_CR3) 2021; 13
K Maiese (3639_CR11) 2020; 17
C Yang (3639_CR15) 2021; 49
W Deng (3639_CR13) 2019; 294
K Maiese (3639_CR31) 2014; 11
L Yao (3639_CR44) 2016; 20
Z Lu (3639_CR42) 2017; 10
T Lipenga (3639_CR4) 2021; 157
O Lyros (3639_CR18) 2019; 9
ZW Reichenbach (3639_CR25) 2019; 144
F Fang (3639_CR12) 2022; 13
H Zhang (3639_CR36) 2016; 57
References_xml – volume: 49
  start-page: 300060521101993
  issue: 5
  year: 2021
  ident: 3639_CR15
  publication-title: J Int Med Res
– volume: 2129
  start-page: 1
  year: 2020
  ident: 3639_CR2
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-0716-0377-2_1
– volume: 9
  start-page: 330
  issue: 2
  year: 2019
  ident: 3639_CR18
  publication-title: Am J Cancer Res
– volume: 246
  start-page: 1244
  issue: 11
  year: 2021
  ident: 3639_CR35
  publication-title: Exp Biol Med (Maywood)
  doi: 10.1177/1535370221992703
– volume: 13
  start-page: 20481
  issue: 16
  year: 2021
  ident: 3639_CR41
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.203430
– volume: 157
  year: 2021
  ident: 3639_CR4
  publication-title: Environ Int
  doi: 10.1016/j.envint.2021.106880
– volume: 42
  start-page: 491
  issue: 6
  year: 2011
  ident: 3639_CR43
  publication-title: J Mol Histol
  doi: 10.1007/s10735-011-9347-1
– volume: 546
  year: 2022
  ident: 3639_CR6
  publication-title: Cancer Lett
– volume: 57
  start-page: 370
  issue: 4
  year: 2016
  ident: 3639_CR36
  publication-title: J Radiat Res
  doi: 10.1093/jrr/rrw030
– volume: 13
  start-page: 1371
  issue: 1
  year: 2022
  ident: 3639_CR20
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-29018-9
– volume: 11
  start-page: 2835
  issue: 9
  year: 2021
  ident: 3639_CR1
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2021.03.009
– volume: 33
  start-page: 785
  issue: 8
  year: 2014
  ident: 3639_CR40
  publication-title: Hum Exp Toxicol
  doi: 10.1177/0960327113510537
– volume: 12
  start-page: 31
  issue: 1
  year: 2022
  ident: 3639_CR8
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-21-1059
– volume: 6
  start-page: 19907
  issue: 23
  year: 2015
  ident: 3639_CR17
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4529
– volume: 13
  start-page: 659
  year: 2021
  ident: 3639_CR39
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S275172
– volume: 237
  year: 2022
  ident: 3639_CR24
  publication-title: Pathol Res Pract
– volume: 13
  start-page: 45
  issue: 1
  year: 2020
  ident: 3639_CR34
  publication-title: Cell Mol Bioeng
  doi: 10.1007/s12195-019-00602-2
– volume: 10
  start-page: 9489
  issue: 9
  year: 2017
  ident: 3639_CR42
  publication-title: Int J Clin Exp Pathol
– volume: 294
  start-page: 5261
  issue: 14
  year: 2019
  ident: 3639_CR13
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA118.006122
– volume: 219
  year: 2021
  ident: 3639_CR28
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2020.107692
– volume: 23
  start-page: 1353
  issue: 3
  year: 2022
  ident: 3639_CR30
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23031353
– volume: 12
  start-page: S339
  issue: Suppl 2
  year: 2021
  ident: 3639_CR5
  publication-title: J Gastrointest Oncol
  doi: 10.21037/jgo-2019-gi-08
– volume: 12
  start-page: 1847
  issue: 8
  year: 2022
  ident: 3639_CR27
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-21-0282
– volume: 31
  start-page: 991
  issue: 3
  year: 2011
  ident: 3639_CR33
  publication-title: Anticancer Res
– volume: 17
  start-page: 327
  issue: 3
  year: 2020
  ident: 3639_CR11
  publication-title: Curr Neurovasc Res
  doi: 10.2174/1567202617666200327125257
– volume: 144
  start-page: 95
  year: 2019
  ident: 3639_CR25
  publication-title: Adv Cancer Res
  doi: 10.1016/bs.acr.2019.05.004
– volume: 13
  start-page: 11050
  issue: 4
  year: 2022
  ident: 3639_CR12
  publication-title: Bioengineered
  doi: 10.1080/21655979.2022.2068738
– volume: 25
  start-page: 560
  issue: 6
  year: 2012
  ident: 3639_CR23
  publication-title: Dis Esophagus
  doi: 10.1111/j.1442-2050.2011.01279.x
– volume: 1
  start-page: 83
  issue: 3
  year: 2016
  ident: 3639_CR9
  publication-title: J Transl Sci
  doi: 10.15761/JTS.1000112
– year: 2022
  ident: 3639_CR7
  publication-title: Oncol Rep
  doi: 10.3892/or.2022.8333
– volume: 6
  start-page: 6218
  issue: 8
  year: 2015
  ident: 3639_CR14
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3358
– volume: 13
  year: 2022
  ident: 3639_CR16
  publication-title: Front Pharmacol
– volume: 41
  start-page: 771
  issue: 4
  year: 2009
  ident: 3639_CR10
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2008.07.025
– volume: 57
  start-page: 513
  issue: 5
  year: 2018
  ident: 3639_CR22
  publication-title: J Am Assoc Lab Anim Sci
  doi: 10.30802/AALAS-JAALAS-18-000005
– volume: 24
  start-page: 65
  issue: 1
  year: 2019
  ident: 3639_CR26
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2018.11.011
– volume: 430
  start-page: 266
  issue: 2
  year: 2017
  ident: 3639_CR29
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2017.07.025
– volume: 174
  start-page: 4637
  issue: 24
  year: 2017
  ident: 3639_CR38
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13894
– volume: 40
  start-page: 4486
  issue: 26
  year: 2021
  ident: 3639_CR19
  publication-title: Oncogene
  doi: 10.1038/s41388-021-01860-z
– volume: 13
  start-page: 1009
  issue: 5
  year: 2021
  ident: 3639_CR3
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13051009
– volume: 9
  start-page: 565
  issue: 7
  year: 2008
  ident: 3639_CR21
  publication-title: Curr Drug Targets
  doi: 10.2174/138945008784911750
– volume: 20
  start-page: 1673
  issue: 9
  year: 2016
  ident: 3639_CR44
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12862
– volume: 11
  start-page: 378
  issue: 4
  year: 2014
  ident: 3639_CR31
  publication-title: Curr Neurovasc Res
  doi: 10.2174/1567202611666140912115107
– volume: 42
  start-page: 323
  issue: 1
  year: 2023
  ident: 3639_CR37
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-023-10087-1
– volume: 62
  start-page: 142
  year: 2015
  ident: 3639_CR32
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2015.03.007
SSID ssj0055611
Score 2.3736377
Snippet Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct...
Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 580
SubjectTerms Animals
Apoptosis
CCN Intercellular Signaling Proteins - genetics
CCN Intercellular Signaling Proteins - metabolism
CCN Intercellular Signaling Proteins - physiology
Cell Line, Tumor
Cell Movement
Cell Plasticity - genetics
Cell Proliferation
Epithelial-Mesenchymal Transition - genetics
Esophageal Neoplasms - genetics
Esophageal Neoplasms - metabolism
Esophageal Neoplasms - pathology
Esophageal Squamous Cell Carcinoma - genetics
Esophageal Squamous Cell Carcinoma - metabolism
Esophageal Squamous Cell Carcinoma - pathology
Gene Knockdown Techniques
Humans
Intercellular Signaling Peptides and Proteins - genetics
Intercellular Signaling Peptides and Proteins - metabolism
Intercellular Signaling Peptides and Proteins - physiology
Male
Medicine
Medicine & Public Health
Mice
Mice, Nude
Neoplastic Stem Cells - pathology
Oncology
Phenotype
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins - physiology
Research Article
Title Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness
URI https://link.springer.com/article/10.1007/s12094-024-03639-6
https://www.ncbi.nlm.nih.gov/pubmed/39093516
https://www.proquest.com/docview/3087356291
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RrYS48H4sj5WRuEFK7DiJfdxCl8KqFRJdUU6R4zhQwXoDyR6WE_-BM3-OX8JMHlRQhNR7bCfj8cznzDczAI8iimVqVwZSChmgh-KBVrIIRBFGpnDaOk35zgeHyf5CvjqOj_uksHpguw8hydZSnya7iZDK2OKUFHzUQbIF2zFXWo1ge_ri3XxvsMDU8ZH3CTL_HvmnEzqDLM9ERVtnM7sCi-E1O47Jx511k-_Yr39VcDzvd1yFyz36ZNNOXa7BBeevw8WDPr5-A37MPdrHAm_mbFWyty_fvOZPn8_nnFEHD2omUTPihK2aTXViWYXIm0jZzYadeOaoIQJaJ5y__rw29EuBUViAWWpX5FdLw_INq9dVR73175mrKCHkE56An9--LykNyn7YLHF8Qw605ZIx4wtGtabJIt-Eo9ne0bP9oG_gEFihVRPwWBXWJiZ1KcIaJ22onEgKxDi6TEyeRqWNXYkXJiVMrkPpDKIjKUoemzwUNroFI7_y7g4wx11ccuVSLYw0eGUMRZlKrQRRJOM4GsPjYUOzqivTkZ0WZCaBZyjwrBV4lozh4bDnGZ4mkoXxDsWSUX3ECCGh5mO43SnD7_kiTUFjjqOfDBub9Qe-_s9id8_3-D24JKjFcEsMvw-j5svaPUDc0-QTVPPZ7u7hpFf3CWwtxPQXkE3_Zw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZokaAXVMqjC5QaqbcSETvOw8eKttqy3QqpW7U3y3EmsBLrDSR72Bv_gTN_jl_CTDZpVRUh9R47kj9n5pvM42NsL6JcpoYyUEqqAD2UCHSmikAWYWQL0A409TuPz5Lhhfp0FV91TWF1X-3epyRbS33T7CZDGmOLW1LyUQfJGnuIZCAj3YILedDbX9J7FF17zL_X3XZBd3jlnZxo62qON9mTjiPygxWoT9kD8Fvs0bjLgj9jv0cerViB8TOfl_zy5Pyz-HA4GglOOhsk-VBzqtyaN8tq6niF_JhKp5sln3oOJFuANgT3r78vLAX-nH7ec0eiQn4-szxf8npRrQpk_RcOFbVtfMN7-ufnrxk1K7mvyxmub8jNtRVf3PqC00RospvP2eT4aPJxGHQyC4GTOmsCEWeFc4lNIUXyAcqFGcikQCaiy8TmaVS6GEoMazJpcx0qsMhhlCxFbPNQuugFW_dzD9uMg4C4FBmkWlplMbALZZkqnUkqZIzjaMD2-4M31WqYhrkZm0wwGYTJtDCZZMDe9dgYvPN0FtYDHouhKYYREjctBuzlCrTr_SJNqV2Bq9_3KJrus6z_87JX93t8lz0eTsan5vTkbPSabUgSBW5Lud-w9ebHAnaQqTT52_Zi_gUD1OLm
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKK1VcEJRHl1eNxA2ijR3n4WNFWbVdWlWiFb1ZjjNuK7HewGYPe-M_cObP8UuYyYNSFSFxjx3J32Tmc-abGcZeJ5TL1OAjpaSKMEKJSBeqimQVJ7YC7UBTvfPRcbZ_pg7P0_M_qvhbtfuQkuxqGqhLU2jGdeXH14VvMqaWtrg9JSJ1lN1hG-iOBVn6mdwdfDHNfhR9qczf190MR7c45q38aBt2JvfZvZ4v8t0O4AdsDcIW2zzqM-IP2Y9pQI9W4V2azz3_dPDxRIz3plPBaeYGjX9YcFJxzZtVfeV4jVyZZNTNil8FDjTCAP0J7r_4srT0E4DTj3zuaMBQmM8sL1d8saw7sWy44FBTCcdntNmf377PqHDJXa5muL6hkNeqv7gNFafu0ORDH7HTyfvTd_tRP3IhclIXTSTSonIusznkSERAubgAmVXISrTPbJkn3qXg8YpTSFvqWIFFPqOkF6ktY-mSx2w9zANsMw4CUi8KyLW0yuIlL5Y-V7qQJGpM02TE3gwHb-qusYa5bqFMMBmEybQwmWzEXg3YGLR_OgsbAI_FUEfDBEmcFiP2pAPt936JpjSvwNVvBxRN_4ku_vGyp__3-A7bPNmbmA8Hx9Nn7K6k-cCtqvs5W2--LuEFkpamfNna5S_n3eci
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Knockdown+of+WISP1%2FDKK1+restrains+phenotypic+plasticity+in+esophageal+squamous+cell+carcinoma+by+suppressing+epithelial-mesenchymal+transition+and+stemness&rft.jtitle=Clinical+%26+translational+oncology&rft.au=Fu%2C+C&rft.au=Lu%2C+Z&rft.au=Shi%2C+J&rft.au=Liu%2C+F&rft.date=2025-02-01&rft.eissn=1699-3055&rft.volume=27&rft.issue=2&rft.spage=580&rft_id=info:doi/10.1007%2Fs12094-024-03639-6&rft_id=info%3Apmid%2F39093516&rft.externalDocID=39093516
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1699-3055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1699-3055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1699-3055&client=summon